What Amplify Partners does

Amplify Partners is a Menlo Park-based venture capital firm founded in 2012 that invests at the seed stage in technical founders building infrastructure, developer tools, and applied AI companies. The firm is currently investing out of its sixth fund vintage and is publicly known for early, conviction-led positions in category-defining technical businesses, including being the first institutional investor in Datadog and Fastly. Its core operational differentiator is a dedicated Build Team of operating partners that supports portfolio companies with hands-on engineering, product, and go-to-market assistance, alongside a 150+ technical founder community that compounds sourcing and recruiting advantages across vintages.

The firm's business model is conventional venture fund management: it raises limited-partner capital in multi-year fund vintages and generates revenue from management fees on committed capital, supplemented by carried interest on realized gains. Differentiation is sought through thematic focus (AI infrastructure, developer platforms, and now life sciences via the recently launched Amplify Bio initiative), content-driven deal sourcing (a long-running writing and newsletter program and the 2025 Amplify Writing Fellowship), and concentrated lead positions at seed. Recent 2025–2026 activity shows multiple lead investments across AI, data, and biology, with co-investment alongside tier-one firms including Andreessen Horowitz, Sequoia, and Kleiner Perkins, and an emerging geographic footprint extending into Paris and New York from its historical Bay Area base.

The 2025 launch of Amplify Bio, the formalization of the Writing Fellowship, and ongoing deployment of fund six together indicate a firm scaling both vertically (new thesis areas) and operationally (new programmatic offerings), while retaining a seed-first, founder-led posture.

Name

Amplify Partners

Legal name

Amplify Partners

Website

https://amplifypartners.com

Company type

Private

Founded year

2012

Operating status

Operating

Headcount range

11–50 employees

Short description

Amplify Partners is a Menlo Park-based seed-stage venture capital firm, founded in 2012, that invests in technical founders building AI, infrastructure, and life sciences companies, currently deploying its sixth fund and supported by a Build Team of operating partners.

Ownership category

akta.pro rank

Headquarters

HQ city

Menlo Park

HQ country

United States

HQ region

North America

Offices2 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales

Revenue model

1. Venture fund management fees & carried interest: Amplify earns revenue through standard venture capital fund economics: recurring management fees on assets under management across its fund vehicles, plus carried interest (carry) on profits from successful exits. Amplify is 'currently investing out of our sixth fund,' indicating six successive fund vintages since founding in 2012. Geographic scope is global via the fund, with investments primarily in U.S.-headquartered technical founders.

Go-to-market motion1 record

Distribution channels5 records

Marketing channels8 records

Core offering

Amplify Partners is an early-stage venture capital firm that invests in technical founders (engineers, researchers, scientists) building the next generation of applications, models, tools, and infrastructure. The firm leads investments from a company's first round through Series A and supports founders all the way until IPO, currently investing out of its sixth fund since founding in 2012. Beyond capital, Amplify provides an in-house Build Team of operating partners delivering structured support across GTM/sales, growth/marketing, talent/recruiting, and design, plus a 150+ founder community and dedicated Amplify Bio vertical for digital biology.

Product overview

Amplify Partners operates a single primary platform — an early-stage venture capital fund dedicated to technical founders — augmented by several named programs and services. The core offering is the Amplify Partners fund, currently investing out of its sixth fund and leading rounds from first-round through Series A with support continuing through IPO; this core fund sits alongside Amplify Bio, a dedicated life-sciences investment vertical for digital biology founders. Wrapped around both funds is the Amplify Build Team, an in-house operating group delivering GTM/Sales (Tim Babcock, Mark LaRosa), Growth + Marketing (Justin Gage), Talent + Recruiting (Natasha Katoni, Sam Dore), and Design (Joshua Goldenberg) services to portfolio companies. The Amplify Founder Community provides events, workshops, and a private #amplify-founders Slack channel for 150+ founders across 100+ portfolio companies, and the Amplify Writing & Newsletter program (including the 'Projects to Know' newsletter and the Amplify Writing Fellowship) publishes technical content from and about the portfolio. Together these constitute Amplify Partners' offering: a fund-plus-Build-Team-plus-community-plus-content platform for backing technical founders.

Differentiator

Problem solved

Functional benefit

Brands

• Amplify Bio: The firm's dedicated sub-brand / initiative investing in technical founders building digital biology platforms and infrastructure for the life sciences.

Products and services

• Amplify Partners Core Fund
• Amplify Bio
• Amplify Build Team
• Amplify Founder Community
• Amplify Writing Fellowship
• Projects to Know Newsletter

Quantifiable outcome

• First investor in Datadog (IPO 2019), Fastly (IPO), and multiple other unicorns
• +2 more outcomes

Named customers8 records

Segments3 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Partnerships

One partnership is on record.

• Amplify Bio Advisorsflagship internal initiativeStrategic or Co-development PartnerAmplify Bio is the firm's dedicated life sciences vertical, partnering with Bio Advisors including Hani Goodarzi (Venture Partner), Steve Holtzman, Michael Fischbach, and Patrick Loerch to back digital biology founders from day one across digital biology portfolio (Axiom, Achira, Tahoe, Chai Discovery, Bexorg, Waypoint Bio, Centivax, Infinitopes, etc.).

Scale indicators6 records

Recent moves5 records

Expansion highlights5 records

Broad incumbents

• Andreessen Horowitz: Multi-stage venture firm with a deep infrastructure and developer-tools practice (e.g., co-led Temporal's $5B Series D with Amplify participation). Both firms court technical founders, but a16z operates at much larger fund sizes and broader stage range.
• Sequoia Capital: Legendary multi-stage VC that co-invested with Amplify in Temporal and Engram. Comparable in backing technical founders at seed/Series A but with far larger funds and global reach.
• Kleiner Perkins: Historical Bay Area VC with deep developer-tools and AI heritage; recurring co-investor with Amplify on Allium, Engram, and Avoca. Comparable technical-founder thesis at early stage but with much broader sector mandate.
• Lightspeed Venture Partners: Multi-stage firm with a strong enterprise infrastructure franchise; co-led Reactor's $59M Series A and participated in Temporal's $300M Series D alongside Amplify. Comparable technical-founder focus but broader stage coverage.
• Bessemer Venture Partners: Multi-stage cloud-and-infrastructure investor that led Foxglove's $40M Series B with Amplify participation. Direct overlap on developer-tools and AI infrastructure investments with multi-stage capability.
• Greylock Partners: Long-tenured enterprise and infrastructure VC; led Niteshift's $7M seed with Amplify participation. Both firms back technical founders at the seed/Series A stage.
• Redpoint Ventures: Multi-stage firm with strong developer-tools and AI infrastructure book; led Modal's $16M Series A and co-led Scribe's $75M Series C with Amplify participation. Directly comparable seed/Series A activity in the same sectors.
• General Catalyst: Multi-stage VC active across the same developer-tools and AI stack; co-invested with Amplify in Waypoint Bio, Avoca, and Engram. Comparable technical-founder targeting but with a much broader stage range.
• Index Ventures: Transatlantic VC with strong developer-tools and infrastructure franchises; existing investor in Temporal alongside Amplify. Highly comparable technical-founder thesis with similar seed/Series A positioning.

Direct peers

• Lux Capital: Technical-founding-focused seed/Series A investor with deep science-and-compute orientation; co-invested with Amplify in Modal and Waypoint Bio. Direct peer in technical-founder thesis and stage focus, particularly in frontier-tech and bio-compute.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key highlights7 records

Customer concentration

• Xx.com/amplifypartners
• LinkedInlinkedin.com/company/2926380
• Facebookfacebook.com/amplifypartners

Revenue estimate

Valuation estimate

Number of profiles

Profiles23 records

Subsidiaries1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments314 records

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Amplify Partners